230 related articles for article (PubMed ID: 3021863)
1. Anthralin (1,8-dihydroxyanthrone) is a potent inhibitor of leukotriene production and LTB4-omega oxidation by human neutrophils.
Schröder JM
J Invest Dermatol; 1986 Nov; 87(5):624-9. PubMed ID: 3021863
[TBL] [Abstract][Full Text] [Related]
2. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan.
Williams JD; Lee TH; Lewis RA; Austen F
J Immunol; 1985 Apr; 134(4):2624-30. PubMed ID: 2982947
[TBL] [Abstract][Full Text] [Related]
3. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
Lee TH; Mencia-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF
J Clin Invest; 1984 Dec; 74(6):1922-33. PubMed ID: 6096400
[TBL] [Abstract][Full Text] [Related]
4. Phorbol myristate acetate and the calcium ionophore A23187 synergistically induce release of LTB4 by human neutrophils: involvement of protein kinase C activation in regulation of the 5-lipoxygenase pathway.
Liles WC; Meier KE; Henderson WR
J Immunol; 1987 May; 138(10):3396-402. PubMed ID: 3033073
[TBL] [Abstract][Full Text] [Related]
5. 1-[4-[3-[4-[bis(4-fluorophenyl)hydroxymethyl]-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone(AHR-5333): a selective human blood neutrophil 5-lipoxygenase inhibitor.
Graff G; Anderson LA
Prostaglandins; 1989 Oct; 38(4):473-96. PubMed ID: 2554366
[TBL] [Abstract][Full Text] [Related]
6. Auranofin stimulates LTA hydrolase and inhibits 5-lipoxygenase/LTA synthase activity of isolated human neutrophils.
Betts WH; Hurst NP; Murphy GA; Cleland LG
Biochem Pharmacol; 1990 Apr; 39(7):1233-7. PubMed ID: 2157444
[TBL] [Abstract][Full Text] [Related]
7. Oxidation of leukotrienes at the omega end: demonstration of a receptor for the 20-hydroxy derivative of leukotriene B4 on human neutrophils and implications for the analysis of leukotriene receptors.
Clancy RM; Dahinden CA; Hugli TE
Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5729-33. PubMed ID: 6091105
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of arachidonic acid by peripheral and elicited rat polymorphonuclear leukocytes. Formation of 18- and 19-oxygenated dihydro metabolites of leukotriene B4.
Powell WS; Gravelle F
J Biol Chem; 1990 Jun; 265(16):9131-9. PubMed ID: 2160957
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of leukotriene B4 synthesis in neutrophils from patients with rheumatoid arthritis by a single oral dose of methotrexate.
Sperling RI; Coblyn JS; Larkin JK; Benincaso AI; Austen KF; Weinblatt ME
Arthritis Rheum; 1990 Aug; 33(8):1149-55. PubMed ID: 2167685
[TBL] [Abstract][Full Text] [Related]
10. The leukotriene B4 paradox: neutrophils can, but will not, respond to ligand-receptor interactions by forming leukotriene B4 or its omega-metabolites.
Haines KA; Giedd KN; Rich AM; Korchak HM; Weissmann G
Biochem J; 1987 Jan; 241(1):55-62. PubMed ID: 3032161
[TBL] [Abstract][Full Text] [Related]
11. In vitro inhibition of leukotriene B4 formation by exogeneous 5-lipoxygenase inhibitors is associated with enhanced generation of 15-hydroxy-eicosatetraenoic acid (15-HETE) by human neutrophils.
Fogh K; Herlin T; Kragballe K
Arch Dermatol Res; 1988; 280(7):430-6. PubMed ID: 2849922
[TBL] [Abstract][Full Text] [Related]
12. Anthralin inhibition of mouse epidermal arachidonic acid lipoxygenase in vitro.
Bedord CJ; Young JM; Wagner BM
J Invest Dermatol; 1983 Dec; 81(6):566-71. PubMed ID: 6417248
[TBL] [Abstract][Full Text] [Related]
13. Development of a system for evaluating 5-lipoxygenase inhibitors using human whole blood.
Sweeney FJ; Eskra JD; Carty TJ
Prostaglandins Leukot Med; 1987 Jun; 28(1):73-93. PubMed ID: 3039537
[TBL] [Abstract][Full Text] [Related]
14. Colchicine inhibits ionophore-induced formation of leukotriene B4 by human neutrophils: the role of microtubules.
Reibman J; Haines KA; Rich AM; Cristello P; Giedd KN; Weissmann G
J Immunol; 1986 Feb; 136(3):1027-32. PubMed ID: 3001184
[TBL] [Abstract][Full Text] [Related]
15. Studies on leukotriene B4 omega-oxidation in human leukocytes.
Nadeau M; Fruteau de Laclos B; Picard S; Braquet P; Corey EJ; Borgeat P
Can J Biochem Cell Biol; 1984 Dec; 62(12):1321-6. PubMed ID: 6099214
[TBL] [Abstract][Full Text] [Related]
16. Effects of a 5-lipoxygenase inhibitor, AA861, on lipoxygenase metabolism and superoxide anion generation by human polymorphonuclear leukocytes--potentiation of superoxide anion generation by LTB4.
Tanaka K; Abe M; Shigematsu N
Int Arch Allergy Immunol; 1992; 98(4):361-9. PubMed ID: 1330136
[TBL] [Abstract][Full Text] [Related]
17. Studies on the release of leukotrienes and histamine by human lung parenchymal and bronchial fragments upon immunologic and nonimmunologic stimulation. Effects of nordihydroguaiaretic acid, aspirin, and sodium cromoglycate.
Salari H; Borgeat P; Fournier M; Hebert J; Pelletier G
J Exp Med; 1985 Dec; 162(6):1904-15. PubMed ID: 2415659
[TBL] [Abstract][Full Text] [Related]
18. Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes.
Shak S; Goldstein IM
J Biol Chem; 1984 Aug; 259(16):10181-7. PubMed ID: 6088485
[TBL] [Abstract][Full Text] [Related]
19. Dapsone inhibits the generation of 5-lipoxygenase products in human polymorphonuclear leukocytes.
Wozel G; Lehmann B
Skin Pharmacol; 1995; 8(4):196-202. PubMed ID: 7488396
[TBL] [Abstract][Full Text] [Related]
20. Leukotriene B4 metabolism in neutrophils of patients with chronic granulomatous disease: phorbol myristate acetate decreases endogenous leukotriene B4 via NADPH oxidase-dependent mechanism.
Hamasaki T; Sakano T; Kobayashi M; Sakura N; Ueda K; Usui T
Eur J Clin Invest; 1989 Aug; 19(4):404-11. PubMed ID: 2550242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
